These terms set out the basis on which this website and its scientific, commercial and general information may be accessed and used.
Document information
Last updated 26 July 2026. These terms explain the basis on which the AVIX Pharmaceuticals website and its scientific, commercial and general information may be accessed and used.
01 · Website
This website is operated by AVIX Pharmaceuticals Limited, registered in England and Wales under company number 11299779. Its content is provided for general information, investor discussion, scientific communication and commercial engagement across the AVIX portfolio.
02 · Health information
Website content is not medical advice and must not be used to diagnose, treat, cure or prevent disease. Venture-specific product information should be interpreted with the status and disclaimers presented for that venture.
03 · Science & commerce
Some information relates to ongoing analysis, preliminary findings, forecasts, target dates or future plans. These may change and are not guarantees of performance, approval, launch, investment return, licensing or acquisition.
04 · Intellectual property
Unless stated otherwise, website text, branding, graphics, layouts and media are owned by or licensed to AVIX Pharmaceuticals Limited. Commercial reproduction requires permission.
05 · Use
You must not misuse the website, attempt unauthorised access, introduce malicious code, impersonate others or use website content unlawfully.
06 · External links
Links to third-party websites or services are provided for convenience and context. Those services remain outside AVIX Pharmaceuticals’ control.
07 · Liability
To the extent permitted by law, the website is provided without guarantees of uninterrupted availability or complete accuracy. These terms are governed by the laws of England and Wales.
08 · Contact
For questions about these terms, email hello@avixpharma.com.
